49 completed, 8 unknown, 6 recruiting, 4 terminated. 40 Not applicable, 11 Phase 2, 4 Phase 1, 2 Phase 4.
Follow Platelet Glycoprotein IV Deficiency: new trials by email Literature Review of Platelet Glycoprotein IV Deficiency trials Research Report on Platelet Glycoprotein IV Deficiency
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sex Differences in Cold-Induced Changes in Maximal Fat Oxidation Cold temperature, Room Temperature - Exercise | Not applicable | Recruiting | Colorado State University | 20 | 2026-04-15 | 2026-05-15 |
| Effects of Normobaric Hypoxic Training in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) HYPOTRAIN, NORMOTRAIN - MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, Normobaric Hypoxia | Not applicable | Completed | University of Trieste | 16 | 2025-09-01 | 2026-08-17 |
| A Study of Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Participants With Obesity or Overweight With Type 2 Diabetes Bimagrumab, Tirzepatide, Bimagrumab Placebo - Obesity, Overweight | Phase 2 | Withdrawn | Eli Lilly and Company | 2025-05-23 | 2025-09-24 | |
| Heart Failure in Patients With Diabetes: Cells, Crosstalk and Consequences Diabetes Mellitus Type 2, Heart Failure | Recruiting | University of Leeds | 600 | 2025-02-26 | 2025-02-28 | |
| COmmencing Menopausal HOrmone Replacement Therapy and the Effect on Metabolic-dysfunction Associated Steatotic Liver Disease: a Pilot Mechanistic Study Menopausal hormone therapy - Menopause, Metabolic Dysfunction Associated Steatotic Liver Disease | Phase 1 | Recruiting | University of Oxford | 10 | 2025-01-01 | 2025-01-13 |
| Effects of an Immersive Virtual Reality Program Physical activity - Physical Activity, Virtual Reality | Not applicable | Unknown | Universidad Autónoma de Chile | 30 | 2024-12-01 | 2024-11-19 |
| A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight Bimagrumab, Tirzepatide, Bimagrumab Placebo - Obesity, Overweight | Phase 2 | Active not recruiting | Eli Lilly and Company | 252 | 2024-10-21 | 2026-05-26 |
| Autologous Nanofat for Treatment of Atrophic Scars Autologous Nanofat Injection, Topical - Postburn Scars; Posttraumatic Scars, Atrophic Scar | Not applicable | Completed | Benha University | 20 | 2024-10-01 | 2026-08-13 |
| Evaluation of the BTL-785F Device for Submental Fat Reduction and Neck Rejuvenation BTL-785-7 - Fat Burn | Not applicable | Completed | BTL Industries Ltd. | 37 | 2023-07-26 | 2024-10-16 |
| Dairy Lipids and Cardiometabolic Risk Low-fat dairy products, Whole-fat dairy products, Milk polar lipid enriched whole-fat dairy products - Morbid Obesity | Not applicable | Recruiting | Hospices Civils de Lyon | 75 | 2023-06-28 | 2025-06-18 |
| Fat Quality and Postprandial Inflammation Fat intake - Inflammatory Response, Inflammation | Not applicable | Completed | Göteborg University | 18 | 2023-02-07 | 2024-02-28 |
| Effect of Ultra-processed Versus Unprocessed Diets on Energy Metabolism Ultra-processed food, high energy density (UPF HL), Ultra-processed food, both low (UPF LL), Ultra-processed food, both high (UPF HH) - Healthy Diet, Obesity | Not applicable | Completed | National Institutes of Health Clinical Center (CC) | 38 | 2022-11-24 | 2026-08-12 |
| Evaluating the Metabolic Effects of Dietary Nitrate Supplementation Beetroot juice - Dietary Nitrate Supplementation | Not applicable | Completed | Institute for Human Development and Potential (IHDP), Singapore | 50 | 2022-07-08 | 2023-09-11 |
| Study of Lipolysis of Visceral Reserve Fat Using Tecar Therapy. Tecar Therapy - Obesity, Visceral, Obesity; Endocrine | Not applicable | Completed | CAPENERGY MEDICAL, SL | 20 | 2022-05-09 | 2025-07-17 |
| Are There Dietary Factors Affecting the Development of Pancreatitis in Patients With Gallstones? diet survey - Diet Habit, Gall Stone | Completed | Istanbul Training and Research Hospital | 120 | 2021-06-01 | 2022-04-14 | |
| Fat Absorption and Metabolism After Roux-en-Y Gastric Bypass Metabolic test, DXA-scan, MRS - Bariatric Surgery | Not applicable | Completed | Hvidovre University Hospital | 24 | 2021-04-01 | 2022-08-23 |
| Mechanisms for Activation of Beige Adipose Tissue in Humans Placebo, Mirabegron, Mirabegron 50 MG - PreDiabetes | Phase 2 | Recruiting | Philip Kern | 65 | 2020-12-07 | 2026-07-07 |
| Analysis of the Performance of 1060 nm Diode and Radio Frequency Prior to Abdominoplasty Venus Bliss - Adipose Tissue Atrophy | Not applicable | Completed | Venus Concept | 12 | 2020-07-01 | 2024-08-21 |
| Impact of an Oligomeric Diet in Intestinal Absorption and Inflammatory Markers in Patients With Crohn Disease Peptidic+Probiotic, Peptidic+Placebo, Polymeric+Placebo - Crohn Disease, Absorption; Disorder, Protein | Not applicable | Unknown | Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | 162 | 2020-02-13 | 2020-03-12 |
| Cow Milk Fat Obesity pRevention Trial Whole (3.25%) cow's milk recommendation, Reduced (1%) fat milk - Obesity, Childhood | Not applicable | Unknown | The Hospital for Sick Children | 534 | 2020-01-01 | 2023-12-13 |
Showing 20 of 71. Sign in to see all of them.
Obesity (25) · Weight Loss (10) · Overweight (7) · Motor Activity (6) · Inflammation (5) · Body Weight (4) · Diabetes Mellitus, Type 2 (4) · Insulin Resistance (4) · Asthma (3) · Diabetes Mellitus (3) · Obesity, Abdominal (3) · Atrophy (2) · Body Weight Changes (2) · Cardiovascular Diseases (2)
Pathological Conditions, Signs and Symptoms (41) · Nutritional and Metabolic Diseases (40) · Signs and Symptoms (31) · Nutrition Disorders (28) · Overnutrition (27) · Body Weight (25) · Overweight (20) · Metabolic Diseases (18) · Behavior (12) · Glucose Metabolism Disorders (11) · Body Weight Changes (9) · Pathologic Processes (8) · Endocrine System Diseases (7) · Digestive System Diseases (6) · Immune System Diseases (6)
Exercise (3) · Pioglitazone (2) · Tirzepatide (2) · bimagrumab (2) · 2-methyl-2-(4-(((4-methyl-2-(4-trifluoromethylphenyl)-thiazol-5-ylcarbonyl)amino)methyl)phenoxy)propionic acid (1) · Absorptiometry, Photon (1) · Angptl4 protein, mouse (1) · Biopsy (1) · Blood Specimen Collection (1) · Cold Temperature (1) · Diet (1) · Diet Surveys (1) · Electric Stimulation (1) · Endosonography (1) · Food, Processed (1)
University of Pittsburgh (3) · Venus Concept (3) · Eli Lilly and Company (2) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2) · Wonik Trade Company, Korea (2) · Agricultural University of Athens (1) · BTL Industries Ltd. (1) · Benha University (1) · Beth Israel Deaconess Medical Center (1) · CAPENERGY MEDICAL, SL (1) · Carol Davila University of Medicine and Pharmacy (1) · Central FITT, Inc (1) · Colorado State University (1) · Columbia University (1) · Cytori Therapeutics (1)
United States (37) · United Kingdom (4) · Canada (3) · South Korea (3) · China (2) · Denmark (2) · France (2) · Netherlands (2) · Singapore (2) · Spain (2) · Argentina (1) · Egypt (1) · Germany (1) · Ireland (1) · Italy (1)
Kevin Hall, Ph.D. (2) · Aimilia Papakonstantinou, PhD (1) · Alison Morris, MD, MS (1) · Anahita Mistry, PhD (1) · Anne E Dixon, MD (1) · Anne E. Dixon, MD (1) · Anne-Marie A Wills, M.D. (1) · Carel le Roux, MBChB, PhD (1) · Christopher Bell (1) · Fernando Holguin, MD, MPH (1) · Frank Greenway, M.D. (1) · Freddy Troost, PhD (1)
PMID 15253184, PMID 16079683, PMID 16418764, PMID 17492425, PMID 20718769, PMID 21607987, PMID 21779417, PMID 22814748, PMID 22823027, PMID 23397317, PMID 23783059, PMID 24077565, PMID 24582471, PMID 25199919, PMID 26278052, PMID 26610598, PMID 27385608, PMID 27797988, PMID 27816052, PMID 28095532, PMID 28103642, PMID 28902034, PMID 28973683, PMID 29746485, PMID 29761785, PMID 31028699, PMID 31067015, PMID 31574911, PMID 32153829, PMID 32385063, PMID 34004390, PMID 34358471, PMID 35384351, PMID 36181063, PMID 37345661, PMID 39014526, PMID 41059542, PMID 41370823, PMID 42128091, PMID 42627603
2014 (1), R01DK072507 (1), R01DK124626 (1), R56HL128134 (1)